Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Brunner, Hermine
- Oscar Viola, Diego
- Dimelow, Richard
- Wilkinson, Christel
- Rizo Rodriguez, Juan Cruz
- Boteanu, Alina
- Kamphuis, Sylvia
- Minden, Kirsten
- Horneff, Gerd
- Anton, Jordi
- Mori, Masaaki
- Yamasaki, Yuichi
- Olaiz, Jose Miyar
- Marino, Rebecca
- van Maurik, Andre
- Okily, Mohamed
- Yanni, Emad
- Wilde, Paul
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Brunner,H,Oscar,D,Dimelow,R,Calvo,I,Wilkinson,C,Rizo,JC,Boteanu,A et al. Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial. 111 RIVER ST, HOBOKEN 07030-5774, NJ:WILEY. 2023 p.p. 2437-2439.
Portal de investigación